论文信息 - ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer. - 字舞流文

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.

S. Shah | D. Bowtell | S. Nik-Zainal | L. Yates | J. Ledermann | C. Scott | E. Swisher | D. Chang | J. Jonkers | I. Ray-Coquard | X. Matías-Guiu | C. Lord | V. Serra | A. Leary | R. Miller | D. Garsed | D. W. Garsed